Novavax
NVAX
#5784
Rank
S$1.42 B
Marketcap
S$8.77
Share price
-1.59%
Change (1 day)
-21.99%
Change (1 year)

Novavax (NVAX) Fails to deliver data

Key failure to deliver metrics for Novavax:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novavax (NVAX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novavax (NVAX) - since 2019

Volume in USD (price x number of shares), data since 2019

Novavax (NVAX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$54.41 M-63.7%
2024S$0.14 B-61.61%
2023S$0.39 B-2.97%
2022S$0.40 B0.26%
2021S$0.40 B22.77%
2020S$0.32 B531.98%
2019S$51.73 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Agenus
AGEN
S$1.24 MS$4.22 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.79 MS$20.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.17 MS$4.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.58 MS$4.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$28.29 MS$0.10 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$29.26 MS$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.76 MS$75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
S$1.74 MS$6.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$61.56 MS$0.39 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
S$6.39 MS$11.98 M๐Ÿ‡บ๐Ÿ‡ธ USA